The End Prescription Drug Ads Now Act aims to eliminate direct-to-consumer drug advertising across all media platforms, ...

Eli Lilly & Co. and health tech company Kalderos Inc. are seeking to revive lawsuits in the DC Circuit after a federal judge ...

Independent Sens. Bernie Sanders of Vermont and Angus King of Maine have introduced a bill that would ban pharmaceutical ...

Industry sources reveal drug companies have stopped negotiating listings on the PBS and in some cases are considering not ...

Eli Lilly ( LLY 0.36%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

President Trump's executive order seeking to tie U.S. drug prices to those abroad could impact future investment in Am ...

Trump administration officials are expected to release more details on their plan to lower prescription drug prices in the ...

If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs. Should ...

While pharmaceutical executives raise valid concerns about the lack of detailed implementation plans for the “Most Favored ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.